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Purpose: Identification of mitochondrial DNA (mtDNA) variations in the inherited cataract patients from south India.
Methods:  Three  families  with  inherited  cataract  of  maternal  origin  were  evaluated.  Clinical  and  ophthalmologic
examinations were performed on available affected as well as unaffected family members. Samples of mtDNA were
amplified using 24 pairs of overlapping primers to analyze the entire mitochondrial genome to screen for variations and
analyzed for both coding and non-coding regions. Bioinformatic analysis was performed to evaluate the effect of nucleotide
variations.
Results: DNA sequence analysis of inherited cataract families showed 72 nucleotide variations, of which 15 were observed
in the major non-coding D-loop region, 3 in the tRNA genes, 5 in the rRNA genes, and 49 in the protein coding region.
Among these variations 56 were reported previously and 16 were novel of which, 12 synonymous substitutions, 2 non-
synonymous substitutions along with a frameshift mutation, and one was in the non-coding region. Nicotinamide adenine
dinucleotide dehydrogenase (NADH) subunit (ND) gene of mtDNA was highly altered, in general, and found to contain
4 variations specific for cataract patients of the first family, six for the second, and one for the third family.
Conclusions: Seventy-two variations were observed in three inherited cataract families. Four variations were specific for
cataract patients of the first family, six for the second, and one for the third family. This is perhaps the first report on the
presence of mitochondrial mutations in inherited cataracts.
Cataracts are the leading cause of blindness in children
with an estimated incidence of 1–6 per 10,000 live births.
About 8.3%–25% of cataracts are familial and inherited in a
Mendelian  fashion  predominantly  as  autosomal  dominant
with complete penetrance. Various phenotypes are described
on the basis of site, appearance and progression of opacity in
the lens. Both clinical and genetic heterogeneity of cataract
have been reported [1,2]. The human lens is made up of
elongated lens fiber cells, which are devoid of cell organelles.
But the lens epithelial cells are actively dividing cells, which
are  nucleated  and  only  during  their  differentiation  and
migration lose their DNA along with other cellular organelles
[3].  New  fiber  cells  are  added  from  the  periphery  of  the
existing cells. The membrane of the lens fiber cells play an
important role in the maintenance of homeostasis as it is
involved in transport of water, ions, and energy for lens fiber
cells. Generally, cataract is caused by alteration in spatial
arrangement of proteins in the lens fibers. Crystallins α-, β-
and γ- are the major protein components of the lens [4-6]. They
undergo  protein–protein  interactions  as  core  biophysical
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properties of crystallins to impart unique function to the eye
[7]. The proteins once formed remain for the individual's
lifetime since there is no major protein turnover in the lens. In
addition mitochondrial debris is also reported to be present
and may cause reduced vision [8].
Mutations  in  various  genes  have  been  reported  to  be
associated  with  various  phenotypes  and  they  include
crystallins, connexins, aquaporin, beaded structural filament
protein 2, transcription factors like paired-like homeodomain
3 (PITX3) and heat shock transcription factor 4 (HSF4), avian
musculoaponeurotic  fibrosarcoma  (MAF)  protein  and
chromosome modifying proteins. Up to today, 39 loci have
been mapped as candidate for cataractogenesis, of which 26
have been found to be associated with mutations in specific
genes [9]. Majority of the mutations are reported to reside in
genes coding for crystallins (50%), followed by connexins
(25%) and the rest are distributed in various transcription
factor  (HSF4),  and  membrane  proteins  (beaded  filament
structural protein [BFSP] and lens intrinsic membrane protein
2 [LIM2]).
The human mitochondrial genome is circular, double-
stranded DNA of 16,569 base pairs (bp) in length, located
within the mitochondrial matrix and present in thousands of
copies in every cell [10]. The electron transport chain, rRNA
and tRNA are coded by mitochondrial genes. Mitochondrial
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181DNA (mtDNA) is inherited through maternal lineage and is
highly polymorphic. Currently used criteria for determining
the likelihood that a missense mutation is pathogenic include:
alteration in the evolutionarily conserved amino acid; absence
TABLE 1. DETAILS OF PCR PRIMERS USED FOR MTDNA AMPLIFICATION [27].
Name Primer sequence 5’→3’ Product size
MIT1F CTCCTCAAAGCAATACACTG 840
MIT1R TGCTAAATCCACCTTCGACC  
MIT2F CGATCAACCTCACCACCTCT 802
MIT2R TGGACAACCAGCTATCACCA  
MIT3F GGACTAACCCCTATACCTTCTGC 860
MIT3R GGCAGGTCAATTTCACTGGT  
MIT4F AAATCTTACCCCGCCTGTTT 887
MIT4R AGGAATGCCATTGCGATTAG  
MIT5F TACTTCACAAAGCGCCTTCC 832
MIT5R ATGAAGAATAGGGCGAAGGG  
MIT6F TGGCTCCTTTAACCTCTCCA 898
MIT6R AAGGATTATGGATGCGGTTG  
MIT7F ACTAATTAATCCCCTGGCCC 975
MIT7R CCTGGGGTGGGTTTTGTATG  
MIT8F CTAACCGGCTTTTTGCCC 814
MIT8R ACCTAGAAGGTTGCCTGGCT  
MIT9F GAGGCCTAACCCCTGTCTTT 827
MIT9R ATTCCGAAGCCTGGTAGGAT  
MIT10F CTCTTCGTCTGATCCGTCCT 886
MIT10R AGCGAAGGCTTCTCAAATCA  
MIT11F ACGCCAAAATCCATTTCACT 987
MIT11R CGGGAATTGCATCTGTTTTT  
MIT12F ACGAGTACACCGACTACGGC 900
MIT12R TGGGTGGTTGGTGTAAATGA  
MIT13F TTTCCCCCTCTATTGATCCC 816
MIT13R GTGGCCTTGGTATGTGCTTT  
MIT14F CCCACCAATCACATGCCTAT 940
MIT14R TGTAGCCGTTGAGTTGTGGT  
MIT15F TCTCCATCTATTGATGAGGGTCT 891
MIT15R AATTAGGCTGTGGGTGGTTG  
MIT16F GCCATACTAGTCTTTGCCGC 840
MIT16R TTGAGAATGAGTGTGAGGCG  
MIT17F TCACTCTCACTGCCCAAGAA 802
MIT17R GGAGAATGGGGGATAGGTGT  
MIT18F TATCACTCTCCTACTTACAG 866
MIT18R AGAAGGATATAATTCCTACG  
MIT19F AAACAACCCAGCTCTCCCTAA 977
MIT19R TCGATGATGTGGTCTTTGGA  
MIT20F ACATCTGTACCCACGCCTTC 970
MIT20R AGAGGGGTCAGGGTTGATTC  
MIT21F GCATAATTAAACTTTACTTC 938
MIT21R AGAATATTGAGGCGCCATTG  
MIT22F TGAAACTTCGGCTCACTCCT 1162
MIT22R AGCTTTGGGTGCTAATGGTG  
MIT23F TCATTGGACAAGTAGCATCC 765
MIT23R GAGTGGTTAATAGGGTGATAG  
MIT24F CACCATCCTCCGTGAAATCA 954
MIT24R AGGCTAAGCGTTTTGAGCTG  
          The annealing temperature for all primers were found to be 61 °C.
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182of the mutation in controls; clinical features commonly linked
to  known  pathogenic  mtDNA  mutations,  defects  in
mitochondrial  morphology,  number  and  enzyme  activities
[11].  Pathogenic  mtDNA  mutations  are  typically
characterized  by  incomplete  penetrance,  even  when
homoplasmic,  presumably  reflecting  interactions  with
environmental and nuclear genetic factors [12]. As a result,
inherited  mtDNA  mutations  may  not  manifest  the  same
pathogenicity in all the offspring of an affected mother [13,
14]. Thus mtDNA mutations identified in rare families or
subjects with a putative mitochondrial genetic disorder are
often uncertain of its pathogenic significance. The mtDNA is
highly polymorphic, and certain polymorphisms are thought
to be risk factors in complex diseases such as diabetes mellitus
[15],  Alzheimer  disease  [16],  Parkinson  disease  [17-20],
bipolar disorder [21,22], and some types of cancer [23,24].
Over 100 mtDNA point mutations associated with human
diseases have been identified, of which about 45 are missense
mutations in protein encoding genes. However, there is no
report  up  to  today  on  complete  mtDNA  variations  in
childhood cataract. Hence, this study was aimed to examine
the mtDNA mutation(s) in childhood cataract.
METHODS
Subjects and methods:  Seventeen families with childhood
cataract, hailing from the coastal Karnataka region of India,
who are attending the Kasturba Hospital (KH), Manipal, India
and  Government  Wenlock  Hospital  (GWH),  Mangalore,
India, were recruited for this study. Clinical information of the
probands was evaluated by a team of expert ophthalmologists
and the details were recorded. Affected status was determined
by  a  history  of  cataract  extraction  or  ophthalmologic
examination,  which  included  slit  lamp  examination  with
dilated  pupils,  visual  acuity  testing,  intraocular  pressure
measurement, and fundus examination by ophthalmologists.
We  studied  the  mtDNA  mutations  in  three  families  with
childhood cataract showing maternal inheritance. The patients
with a history of trauma, intrauterine infection and metabolic
disorders were excluded. Detailed pedigree of the kindred was
ascertained by interviewing the parents or available family
member(s). The clinical details of the patients who previously
had  cataract  extraction  were  obtained  through  medical
records.  The  inclusion  criteria  followed  for  selection  of
cataract families consisted of affected mother with affected as
well as unaffected children available for the study. Four age
and ethnically matched healthy individuals representing each
family were included as control set. We have also earlier ruled
out the presence of candidate gene mutations in these families
[25]. We have included “syndromic cataract” as one of the
exclusion criteria in our study and have considered only non-
syndromic families.
Sample  collection:  About  8–10  ml  of  peripheral  blood
samples  were  collected  in  EDTA  vacutainer  (BD,
Biosciences,  Franklin  Lakes,  NJ)  from  all  participating
individuals after obtaining their informed written consent in
accordance with the Declaration of Helsinki and the Kasturba
Hospital Institutional Ethics Committee. The blood samples
were retained at 4 °C before processing.
Isolation  and  amplification  of  DNA:  Genomic  DNA  was
extracted  from  peripheral  lymphocytes,  using  standard
phenol:chloroform method [26] with some modifications. To
amplify  the  entire  mtDNA,  PCR  was  performed  using
previously defined 24 pairs of overlapping primers (BioServe,
Hyderabad, India) [27] and presented in Table 1. Each PCR
reaction (25 µl) was performed with 50 ng of genomic DNA,
1× PCR buffer, 1.5 M MgCl2, 200 µM dNTPs, 10 pmol each
of  sense  and  antisense  primers  and  1  U  of  Taq  DNA
polymerase  (Finnzymes,  Vantaa,  Finland).  PCR  was
performed  in  VERITI  96  well  thermal  cycler  (Applied
Biosystems, Foster City, CA) with an initial denaturation at
94 °C for 1 min followed by 35 cycles of denaturation at 94
°C for 30 s, primer annealing for 45 s at 61 °C and primer
extension at 72 °C for 2 min. Following this a final extension
was carried out at 72 °C for 5 min (Table 1) [27]. PCR products
were  purified  using  QIA  quick  purification  kit  (Qiagen,
Hilden, Germany).
Sequencing and analysis of complete mitochondrial genome:
The purified amplicons were sequenced using the ABI Big
Dye Terminator cycle sequencing kit, (Applied Biosystems).
Cycling conditions used were: 25 cycles of denaturation at
96 °C for 10 s, annealing at 50 °C for 5 s, and extension at
60  °C  for  4  min.  Extended  products  were  purified  and
analyzed  using  ABI  3130  Genetic  Analyzer  (Applied
Biosystems).  Sequences  obtained  were  aligned  with  the
revised Cambridge reference sequence (rCRS) [28] and the
mutations  were  recorded.  The  observed  alterations  were
compared with mitochondrial databases such as Mitomap and
mtDB as well as with Cat-Map database for their significance.
The mitochondrial sequences variations which were found in
the affected individuals while absent in unaffected members
of the same family were referred to as unique.
RESULTS
Clinical details: All the participants were free from other
diseases such as congenital rubella and vitamin A deficiency
and showed maternal inheritance of cataract (Figure 1 and
Table 2). The degree of opacity of the eyes varied greatly
showing different types of morphology as identified by slit
lamp or by direct flash light examination. The probands of
family mt2A (III:4) and mt3A (II:3) showed more severe
phenotype with central white opacity leading to total cataract
(Figure 2A,B). The proband of family mt3A (II:2) showed
bilateral zonular cataract and we do not have the image of the
cataract phenotype for same. In all the cases, the disease was
found to be progressive in nature with the mean age of 5 years.
The varied degree of opacity among the family members is
suggestive of the presence of probable modulators playing a
critical role in disease manifestation.
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183Sequence  analysis  of  mtDNA:  We  have  sequenced  the
complete  mtDNA  of  14  individuals,  with  10  childhood
cataract patients belonging to 3 cataract families and 4 healthy
individuals. A total of 72 nucleotide variations were observed,
of which 15 were in the major non-coding D-loop region, 3 in
the tRNA genes, 5 in the rRNA genes, and 49 in the protein-
coding region (Figure 3). Of the total 72 variations, 56 were
reported previously and 16 were novel, of these one was in
the non-coding region, 12 were synonymous substitutions, 2
were non-synonymous substitutions and one was frameshift
mutation (Figure 3).
The map generated for the mitochondrial alterations for
each  family  was  analyzed  for  haplogroups.  Family  mt1A
showed M4 haplogroup and family mt2A, mt3A fall in to M39
haplogroups (Figure 4).
The phylogenetic networks and evolutionary branching
was constructed using Network 4.5.1.0. The reduced median
or RM network algorithm was used providing binary data of
the mitochondrial genomic variations.
Figure 1. Pedigrees of the families with inherited cataract included in the study. All the families showed maternal inheritance. The dark squares
and circles represent affected male and female, respectively. The arrow indicates the proband and asterisk indicates the members involved in
the study. Both the sexes were affected. Y represents the age in years. The age at onset is represented in bracket next to the affected member.
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184The SNPs at position 1438, 2706, 3106, 7028, 8860, and
15326 were found in all the samples. These variations were
seen in very high frequency in this population. Of these 8860
and 15326 had a Grantham value of 58 and are reported in
subfertile, abdominal aortic aneurysm, AD, PD, T2DM w/wo
angiopathy,  LHON,  and  dystonia  [13,15,16,19,20,29-31].
Among the other SNPs with high Grantham value include
3394 and 13943, found in over 80 cataract samples. The SNPs
at 8701 and 10398 showed a Grantham value of 58 but were
observed in both cataract and healthy samples. The SNP 3434
showed highest Grantham value of 194 but was found to be
in only healthy subjects.
A3511G leading to Thr69Ala was observed in the mt2A
cataract family. Four variations were found in the cytochrome
oxidase subunit I (COI) region at nucleotide positions 6452,
6524, 7302, and 7319, of these substitutions, those at 6524,
7302, and 7319 were synonymous. The variation at position
6452 was seen in three individuals of family mt3A; of which
one was a healthy individual and two were cataract patients.
Two synonymous variations namely A8679G and A9135G
were observed in the ATP6 region. Of these, A8679G was
found in 3 members of the family, mt3A, and among these
three  one  was  in  healthy  individual  and  other  two  were
observed in patients with cataract. A9135G was observed in
two  cataract  patients  of  the  family  mt1A  and  in  all  the
members of the family mt2A; of which one was healthy and
the other four were in affected individuals. C10797T leads to
Pro13Leu and was observed in three affected members of the
family  mt1A  in  the  nicotinamide  adenine  dinucleotide
dehydrogenase subunit 4 (ND4)region.
Among the sixteen novel mutations; four were observed
in the ND5 gene and all four were synonymous. A12999G was
observed  in  one  healthy  person  and  three  in  affected
individuals of family mt3A; C13668T was observed in two
affected members of the family mt2A; A13956C was seen in
one healthy individual of the family mt1A; C14109T was
observed in two and three individuals of families mt1A and
mt2A, respectively. C14155T synonymous mutation in the
TABLE 2. LIST OF VARIATIONS IDENTIFIED IN HEALTHY AND CATARACT SAMPLES IN RELATION TO REFERENCE SEQUENCE (NC_012920).
Locus Nucleotide change Amino acid change
12S rRNA A1438G ——–
16S rRNA A1811G, A2706G, T2746C, Del3106C ——–
ND1 T3394C, A3397G, A3434G, G3483A, A3511G G3693A, T3847C, C3921A,
T4023G, C4171T
Y30H, M31V, Y43C, E59E, T69A, L129L, L181L, S205S,
T239T, L289L
T1 T4291C ——–
CO1 C6452T, Ins6524A/T, C7028T, T7302C, T7319C L183L, FmsftT207, A375A, L467L, I472I
ATP6 A8679G, A8701G, T8843C, A8860G, A9135G K51K, T59A, I106T, T112A, E203E
CO3 T9540C, A9632C L112L, V142V
TG T10031C ——–
ND3 A10398T, C10400T T114S, T114T
ND4L G10685A A72A
ND4 C10797T, T10873C, A11467G, G11719A, G12007A P13L, P38P, L236L, G320G, W416W
tRNA A12308G ——–
ND5 G12372A, A12999G, C13668T, A13956C, C14109T L12L, A221A, N444N, L540L, F591F
ND6 G12501A M55M
ND5 T12696C, C12705T, A12999G, C13668T, C13943T, A13956C, C14109T Y120Y, I123I, A221A, N444N, T536M, L540L, F591F
ND6 C14155T G173G
Cytb C14766T, T14783C, G14905A, G15043A, T15155C, A15133G, G15301A,
A15326G
T7I, L13L, M53M, G99G, T123T, M129M, L185L, T194A
D-loop A93G, A153G, T152C, A73G, G66T, Ins65T, Del58T, Del57T, Ins55T,
A16206C, C16223T, T16311C, T16445C, T16519C, C16527T
——–
          The novel mutations observed in inherited cataract families are highlighted in bold.
Figure 2. Cataract phenotypes. The eye
images presenting cataract phenotypes
in proband of childhood cataract family
mt2A (III:4; A) and family mt3A (II:3;
B) showing white central dense opacity
leading  to  total  cataract.  The
progression of cataract was observed to
be differential in each eye. The zonular
cataract  phenotype  of  family  mt1A
proband (II:2) is not shown.
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185ND6 gene was observed in only one affected member of the
family  mt3A.  A15133G  was  observed  in  the  ubiquinol-
cytochrome-c reductase complex cytochrome b subunit (MT-
CYB) gene of a healthy individual of the family mt1A. Among
Figure 3. The distribution of mitochondrial sequence variations identified. The sequence variations identified in the coding and non-coding
regions of the mitochondria are shown by arrow heads. The D- loop showed highest number of variation followed by ND1 region and Cytb.
The novel mutations observed in inherited cataract families are highlighted in bold and underlined. The circular mitochondrial genome map
was retrieved from mitomap.
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186the 16 novel variations only one was observed in the D-loop
region (16445) of all members of the family mt3A.
Among  the  72  nucleotide  variations  observed  in  the
families; mt1A, mt2A and mt3A; four (T4023C, T4291C,
C10797T,  and  T15115C)  were  unique  to  the  affected
individuals of mt1A family and seven (T3394C, A3511G,
C4171T,  G12372A,  G12501A,  T12696A,  and  C13943T)
were unique to the mt2A family and one variation (A3511G)
was  unique  to  mt3A  family  (Table  3).  Among  the  four
nucleotide substitutions observed in the mt1A family, two
were synonymous (NADH dehydrogenase subunit-1: T239T,
CYB-T123T),  one  was  non-coding,  and  one  was  a  non-
synonymous (ND4-P13L). T4023C mutation in the NADH
dehydrogenase subunit-1 gene was observed in three affected
members  and  a  non-synonymous  C10797T  (P13L)  was
observed in two affected individuals (I:2, II:2). T15115C in
the CYB region was observed in all three affected members
of this family (mt1A).
Among the seven mutations which were unique to the
second family (mt2A), four were synonymous and three were
non-synonymous. In the ND1 region, three substitutions were
observed  in  four  affected  members  and  of  these  T3394C
Figure  4.  Mitochondrial  haplogroup  analysis  between  childhood
cataract  families.  The  map  generated  for  the  mitochondrial
alterations for each family was analyzed for haplogroups. Family
mt1A showed M4 haplogroup and family mt2A, mt3A fall in to M39
haplogroups. The phylogenetic networks and evolutionary branching
was constructed using Network 4.5.1.0. The reduced median or RM
network  algorithm  was  used  providing  binary  data  of  the
mitochondrial  genomic  variations.  M-Macrohaplogroup,  M4’30-
Superhaplogroup,  M4  haplogroup  for  family  mt1A  and  M39
haplogroup for families mt2A, mt3A.
(Y30H)  and  A3511G  (T69A)  were  non-synonymous  and
C4171T  (L289L)  was  synonymous  substitution.  Four
nucleotide variations unique to the affected individuals were
in  the  ND5  gene  and  of  these,  three  were  synonymous
mutations (T12696C, G12372A, and G12501A) and one was
non-synonymous  C13943T  (T536M)  observed  in  four
members of the second family mt2A. The A3511G mutation
(T69A) in the ND1 region was the only common mutation in
affected members of mt3A family. All these findings show
that T69A is the common mutation in affected members in
two different childhood cataract families mt2A and mt3A
(Table 3). The secondary structure of the wild type and T69A
mutant  ND1  polypeptide  showed  changes  in  the
transmembrane domain of mutant polypeptide. The source of
the structure prediction is shown (Figure 5).
DISCUSSION
In recent years, somatic mitochondrial mutations have been
identified and implicated in the pathogenesis of many diseases
[32-36].  Further  studies  have  reported  identification  of
mitochondrial mutations in various eye disorders including
cataract and congenital cataract [32,33,37,38]. In the present
study,  we  perhaps  for  the  first  time  sequenced  the  entire
mitochondrial genome in patients having congenital cataract
to identify the role of mtDNA mutations if any in childhood
cataract. In our patients, the variation affected ten protein
coding genes (ND1, CO1, ATP6, CO3, ND3, ND4L, ND4,
ND5, ND6, ND5, ND6, and Cytb), two rRNA genes (12s
rRNA  and  16srRNA)  and  non-coding  region  namely
Displacement loop (D-Loop). In our study we have identified
72 nucleotide variations in mitochondria, of which 15 were
observed in the major non-coding D-loop region, 3 in the
tRNA genes, 5 in the rRNA genes and 49 in the protein coding
region. Among the variations 56 were reported previously and
16 were novel of which one was in the non-coding region, 12
synonymous substitutions and 2 were observed to be non-
synonymous substitutions along with a frame shift mutation.
Further,  the  D-loop  was  found  to  be  the  hot  spot  for
mitochondrial  variations.  Among  the  variations  identified
65.05%  was  observed  from  coding  region  indicating  the
strong involvement of mitochondrial variation and oxidative
damage  in  the  pathogenesis  of  congenital  cataract.  In  the
coding region, the ND1 region (10 variations) was the most
frequently altered one followed by Cytochrome-b (Cytb) (8
variations). Taken together, our sequencing results point out
that the high incidence of mtDNA variations might lead to
alteration in aerobic respiration, replication and transcription
of mitochondria during development of eye and this might
play essential role in congenital cataract.
We have performed the clinical, genetic and molecular
characterization of hereditary cataract families. The visual
loss  as  a  sole  clinical  phenotype  was  only  present  in  the
maternal  lineage  of  these  pedigrees,  suggesting  the
involvement of mtDNA mutation(s) in the pathogenesis of
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187childhood  cataract.  Moreover,  these  individuals  were
excluded for the involvement of CRYAA, CRYBB2, CRYGA,
CRYGB, CRYGC, CRYGD, GJA3, GJA8, and PAX6 [25] gene
mutations which are responsible for approximately 90% of the
cases. Sequencing of the complete mitochondrial genome led
to  the  identification  of  several  homoplasmic  mutations,
specific  to  individuals  with  cataract.  Clinical  and  genetic
evaluations revealed the variable severity and age-at-onset in
visual loss. Notably, there was a typical difference in vision
loss and phenotypes in all the three pedigrees. In contrast to
the mitochondrial variations reported in other disorders such
as specific late-onset neurodegenerative diseases [30], cancer
[39], and Noonan syndrome [40], the variations identified in
these families do not share the similarity. This observation is
in agreement with the phenotypic heterogeneity among the
family  members.  Since  we  observed  several  novel  and
reported mutations in individuals with cataract, we presume
that  the  mitochondrial  damage  could  be  more  in  affected
individuals compared to healthy individuals. This would lead
to accumulation of mtDNA damage and ROS generations
finally leading to the damage of lens proteins.
The whole genome screening for mutations/SNPs not
only provided the information on the sequence variations in
childhood cataract but also helped in comparing the mutations
with the previous reports for other diseases. To the best of our
knowledge,  this  is  the  first  report  on  mtDNA  sequence
variation among the cataract patients of Indian sub-continent.
This study indeed may serve as reference for those who would
work on cataract in future. The mtDNA mutations, which are
present only in affected but not in healthy individual of the
family, is of interest and indicate the possible role of these
mutations with disease manifestation.
Mutations at the nucleotide positions 8701 and 10398
have intracellular functions such as calcium-signaling or pH
regulation [41]. Mitochondrial function is multifaceted, and
various  mitochondrial  abnormalities  are  observed  to  be
variable  and  currently  unpredictable  effects  on  different
tissues. Our study evaluated the mitochondrial sequence of
childhood cataract individuals and addressed the impact of
mitochondrial  mutations/polymorphisms  on  biologic
perspectives  of  the  lens.  This  evaluation  may  not  be
comprehensive, but these mitochondrial variations provide a
base line and also help to correlate the findings with reported
variation in other pathological conditions. The localization,
mitotic segregation coupled with tissue specific expression of
such mutated mitochondria have already been reported in
mitochondrial  diseases.  Additionally,  that  the  growing
evidences in mitochondrial studies in cataract have suggested
the  mtDNA  sequence  variation  and  its  association  with
cataract show variation with disease phenotype. None of the
studies was able to provide the mechanism as to how such
sequence  variations  will  promote  cataractogenesis.  Thus
further work on functional studies needs to be undertaken to
delineate  the  molecular  mechanism  behind  mitochondrial
sequence variations in congenital cataract.
Mitochondrial DNA variation is reported in cataract and
other eye related disorders previously including congenital
cataract  [32,33,42,43].  However,  none  of  the  studies  has
sequenced  the  entire  mtDNA  in  congenital  cataracts.  The
present study highlights the importance of defining the precise
nature of mutation which can be used for patient diagnosis as
well as for genetic counseling of maternal lineage relatives.
ND gene of mtDNA being highly altered in general and found
to contain 4 variations specific for cataract patients of the first
family, six for the second and one for the third family. An
earlier  study  has  reported  the  congenital  cataract  as  first
symptom of a neuromuscular disease caused by a novel single
large-scale mitochondrial DNA deletion [32]. Some of the
sequence variations found in the mtDNA are found to be
associated  with  cataract  and  or  with  other  diseases  with
cataract  as  one  of  the  symptoms  [32,44-46].  Additionally
some of them such as T152C, A73G, C16223T, T16311C,
TABLE 3. LIST OF VARIATIONS UNIQUE TO INHERITED CATARACT SAMPLES.
Family Location Nucleotide position Amino acid position
Family mt1A MT-ND1 T 4023 C T 239 T
  MT-T1 T 4291 C Non coding
  MT-ND4 C 10797 T P 13 L
  MT-CYB T 15115 C T 123 T
Family mt2A MT-ND1 T 3394 C Y 30 H
  MT-ND1 A 3511 G T 69 A
  MT-ND1 C 4171 T L 289 L
  MT-ND5 G 12372 A L 12 L
  MT-ND5 G 12501 A M 55 M
  MT-ND5 T 12696 C Y 120 Y
  MT-ND5 C 13943 T T 536 M
Family mt3A MT-ND1 A 3511 G T 69 A
        The term ‘unique’ refers to mitochondrial sequence alterations found in inherited cataract samples while absent in unaffected
        members of the same family.
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188G11778A,  T3394C,  and  C14766T  were  reported  to  be
associated with LHON and other ocular disorders.
The A1438G mutation in the 12S rRNA gene has been
described in Japanese type 2 diabetic group as well as in some
patients with Parkinson disease [47,48]. The T3394C and
G11719A variation of ND1 and ND4 genes is reported in
LHON [49,50]. The variant C7028T in the MT-CO1 gene was
reported in ovarian cancer patients and Parkinson disease
[51,52]. The variant A8679G in ATPAse6 was reported in
patients  having  Persian  LQTS  [53].  The  A8701G  variant
detected in our study was previously identified as altering
mitochondrial matrix pH and intracellular calcium dynamics
and was suspected to be involved in pathogenesis of diseases
[41].  Further,  we  have  also  identified  variants  which  are
reported  in  schizophrenia,  bipolar  disorder,  and  major
depressive disorder [54]. The A12308G variation in tRNA
gene  detected  in  our  study  is  also  previously  reported  in
congenital glaucoma [55] and was shown to be associated with
Figure 5. Electropherogram and polypeptide of wild type and mutant sequence of ND1 region. A: Electropherogram showing wild type and
mutant nucleotide sequence of ND1 region with A>G transition at 3155 nucleotide position. Predicted secondary structure of the wild type
and mutant ND1 polypeptide showing the altered amino acid. B: The architecture of the membrane proteins is reflected in the hydropathy
profile. The helical wheel diagram of predicted polypeptide show change from polar residue to hydrophobic residue. Arrow mark indicates
the altered aminoacid position. The source of the structure prediction is SOOSUI.
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189increased  ROS  production.  One  can  thus  assume  that  the
increased ROS production due to mtDNA alteration during
the  development  of  eye  might  play  significant  role  in
cataractogenesis [56].
The  T3394C,  which  lead  to  Y30H  in  MT-ND1,  was
observed  in  40%  of  the  study  subjects,  whereas  it  was
observed in less than 4.5% of other studies [40,57-60]. The
T4023C silent mutation was observed at a frequency of 30%
in the present study, whereas in other studies, it was reported
to be only at 2% [57,59-61]. The C4171T in MT-ND1 which
lead to a synonymous effect at the 289 position was observed
in 30% of our study population, and it was reported in less
than 1.5% in other studies [62]. The T12696C in MT-ND5, a
silent  mutation  was  observed  in  40%  of  the  individuals
studied; whereas, in other studies [57,63] it was reported to be
less than 4.5%. The C13943T transition in MT-ND5, which
led to T536M, was observed in 40% of the individuals in the
present study, whereas in another study it was reported to be
less than 0.5% [57]. The T15115C substitution in MT-CYB
was observed in 30% in the present study, compared to less
than  5.5%  reported  earlier  [57].  The  mitochondrial  DNA
haplogroup associations are shown in Noonan syndrome and
this  opens  up  new  approaches  to  understand  disease
associations with specific haplogroups [64].
Our  study  suggests  that  there  is  an  involvement  of
mitochondrial genome variation with childhood cataract even
though the human lens fiber cells lack mitochondria. The
novel mutation T69A was found to be common in affected
members of two families (mt2A, mt3A), and P13L mutation
was seen in affected individuals of one childhood cataract
family (mt1A). By observing a common haplogroup 'M39' in
two cataract families mt2A and mt3A we do not claim its
proximity to disease susceptibility. It could be due to the same
ethnic background of both families since this haplogroup is
even reported in other sub populations across southern India.
From  our  observations,  it  is  not  possible  to  generalize
association of any haplogroup with susceptibility to inherited
cataract.  More  research  in  this  area  may  advance  toward
developing an interactive relationship between nuclear genes
and mitochondrial DNA in protecting the lens proteins.
Taken together, our analysis show that mtDNA variations
are commonly found in congenital cataract, but the precise
role  of  such  alteration  is  not  clear.  Further,  additional
functional studies needs to be undertaken to understand how
these individual variants alone or in combination bring about
cataract phenotypes in those patient who harbor such mtDNA
variations. Sligh et al. [65] showed that maternal germ line
transmission of mutant mtDNAs in chimeric mouse model
exhibited ocular abnormalities including congenital cataracts
and functional retinopathy. Currently it is unknown as to how
mitochondrial variations lead to congenital cataract, however
it may be speculated as lens in its early stages of development
may  be  subjected  to  impaired  homeostasis  through  ROS
coupled energy crisis from defective mtDNA. Further, this in
turn might alter lens fiber as well as some of the crystalline
and associated proteins during early eye development leading
to cataractogenesis [65].
The results presented here suggest that the large number
of variations in the mitochondrial genome in the childhood
cataract patients thus, may act in synergy with the nuclear
variations of either candidate genes or other unknown genes
and this remains to be elucidated. Data from such a study may
help in understanding the mechanism of cataractogenesis.
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